J7638 Dexamethasone comp unitDexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Status E: excluded from the PFS by regulation.
J7638 appears in 12 coverage policies from Aetna.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Belimumab (Benlysta) (0818) | listed, no stance | Jun 10, 2026 | payer document |
| Aetna | Benralizumab (Fasenra) (0925) | listed, no stance | Aug 25, 2026 | payer document |
| Aetna | Depemokimab-ulaa (Exdensur) (1098) | listed, no stance (range J7637-J7638) | Aug 10, 2026 | payer document |
| Aetna | Emapalumab-lzsg (Gamifant) (0948) | listed, no stance | Dec 8, 2025 | payer document |
| Aetna | Hypertrophic Scars and Keloids (0389) | covered if criteria are met | May 28, 2026 | payer document |
| Aetna | Inebilizumab-cdon (Uplizna) (0975) | listed, no stance | Aug 11, 2026 | payer document |
| Aetna | Infliximab (0341) | listed, no stance | Oct 5, 2026 | payer document |
| Aetna | Mepolizumab (Nucala) (0897) | listed, no stance (range J7637-J7638) | Aug 5, 2026 | payer document |
| Aetna | Omalizumab (0670) | listed, no stance | Aug 21, 2026 | payer document |
| Aetna | Reslizumab (Cinqair) (0907) | listed, no stance (range J7637-J7638) | Aug 10, 2026 | payer document |
| Aetna | Rituximab (0314) | listed, no stance | Sep 15, 2026 | payer document |
| Aetna | Tezepelumab-ekko (Tezspire) (1003) | listed, no stance (range J7637-J7638) | Aug 6, 2026 | payer document |
Prior authorization required or conditional in IN.
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.